MSB 2.08% 94.0¢ mesoblast limited

Ann: Update on BLA for Graft Versus Host Disease, page-164

  1. 38 Posts.
    lightbulb Created with Sketch. 3
    The bad news is that FDA did not approve the drug. The better news is FDA has not denied the product. FDA is completing the PLI for the producing facility and there is no objectionable conditions.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.